SAM-e Supplement Research References

S-Adenosylmethionine (SAMe). Part1. An Exciting New Antiaging Therapy
http://lef.org/magazine/mag97/march97-report.html


New supplement lauded for treating depression.
Thursday, April 15, 1999, Miami Herald
http://www.herald.com:80/content/today/living/health/digdocs/087259.htm

SAMe is a part of LEF's depression protocol on the web page
http://lef.org/protocols/prtcl-040.shtml

Other SAM-e Websites:

http://www.inetcorp.net.mx/cimar/adenosyl.html
http://www.antiaging-systems.com/aama2z.htm
http://www.antiaging-systems.com/bulletins.htm#MAY 1998
http://lef.org/prod_desc/item120.html
http://lef.org/magazine/hotlines.html
http://lef.org/protocols/abstracts/abstr-040.html
http://lef.org/shop/march-abs97.html
http://lef.org/shop/april-abst97.html
http://lef.org/magazine/mag97/sept97-abs.html

S-Adenosylmethionine (SAMe). Part 2: Fast-Acting Natural Antidepressant
http://lef.org/cgi-local/shop.pl/page=april-report97.html

SAM-e Part 3: The Liver SuperNutrient
http://lef.org/cgi-local/shop.pl/page=june-report972.html

SAMe Part 4: Treatment for Arthritis
http://lef.org/magazine/mag97/sept97-report.html

Selected MedLine references about SAM-e:

S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of
clinical studies.
Bressa GM. Department of Psychiatry, University Cattolica Sacro Cuore
School of Medicine, Rome, Italy.
Acta Neurol Scand Suppl 1994;154:7-14
http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7941964&form=6&d


Parenteral S-adenosyl-methionine (SAMe) in depression: literature review
and preliminary data. Janicak PG, Lipinski J, Davis JM, Altman E, Sharma
RP. Psychopharmacol Bull. 1989;25(2):238-42.

S-adenosylmethionine in depression. A literature review and preliminary
report.Janicak PG, Lipinski J, Davis JM, Comaty JE, Waternaux C, Cohen B,
Altman E, Sharma RP. Ala J Med Sci. 1988 Jul;25(3):306-13. Review.

[S-Adenosyl-L-methionine. Latest results on its efficacy as an
antidepressive agent]. Ortiz P. Actas Luso Esp Neurol Psiquiatr Cienc
Afines. 1988 May-Jun;16(3):201-3.

S-adenosylmethionine in the treatment of depression.
Vahora SA, Malek-Ahmadi P. Texas Tech University, School of Medicine,
Department of Psychiatry, Lubbock 79430. Neurosci Biobehav Rev 1988
Summer;12(2):139-41
http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3050630&form=6&d


[Therapeutic indications of S-adenosyl methionine in neuropsychiatry].
[Article in French]. Tramoni AV, Azorin JM. Clinique de Psychiatrie et de
Psychologie Medicale, C.H.U. Timone, Marseille. Encephale 1988
May-Jun;14(3):113-8
http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2900133&form=6&d


Neuropharmacology of S-adenosyl-L-methionine.
Baldessarini RJ. Am J Med. 1987 Nov 20;83(5A):95-103. Review.

S-adenosylmethionine in the treatment of osteoarthritis. Review of the
clinical studies. di Padova C. Clinical Research Department, BioResearch
S.p.A., Liscate-Milan, Italy. Am J Med. 1987 Nov 20;83(5A):60-5.

Neuropharmacology of S-adenosyl methionine.
Carney MW Clin Neuropharmacol. 1986;9(3):235-43. Review.

The clinical potential of ademetionine (S-adenosylmethionine) in
neurological disorders. Bottiglieri T, Hyland K, Reynolds EH. Metabolic
Disease Center,
Baylor Research Institute, Dallas, Texas. Drugs 1994 Aug;48(2):137-52
http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7527320&form=6&d


S-adenosylmethionine levels in psychiatric and neurological disorders: a
review. Bottiglieri T, Hyland K. Metabolic Disease Center, Baylor
Research
Institute, Dallas, TX 75226. Acta Neurol Scand Suppl 1994;154:19-26
http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7524260&form=6&d


[Ademetionine: the state of the art and future prospects].
[Article in Italian] Almasio P, Pagliaro L
Clinica Medica R, Universita degli Studi di Palermo.
Ann Ital Med Int 1993 Oct;8 Suppl:52S-55S
http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8117523&form=6&d


Review article: S-adenosyl-L-methionine--a new therapeutic agent in
liver
disease? Osman E, Owen JS, Burroughs AK. University Department of
Medicine, Royal Free Hospital and School of Medicine, London, UK.
Aliment Pharmacol Ther 1993 Feb;7(1):21-8
http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8439634&form=6&d


[S-adenosyl-L-methionine (SAMe) and its use in hepatology].
[Article in Italian]. Frezza M, Terpin MM, Peri A
Servizio di Gastroenterologia ed Endoscopia Digestiva, Ospedale di
Cattinara, Trieste. Minerva Gastroenterol Dietol 1992
Jul-Sep;38(3):145-51
http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1299337&form=6&d


Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale
for
its use in liver disease. Chawla RK, Bonkovsky HL, Galambos JT
Department of Medicine, Emory University School of Medicine, Atlanta,
Georgia. Drugs 1990;40 Suppl 3:98-110
http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2081485&form=6&d


Affective disorders and S-adenosylmethionine: a new hypothesis.
Cantoni GL, Mudd SH, Andreoli V. Trends Neurosci 1989 Sep;12(9):319-24
http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2480671&form=6&d


S-adenosyl-L-methionine. A review of its pharmacological properties and
therapeutic potential in liver dysfunction and affective disorders in
relation to its physiological role in cell metabolism. Friedel HA, Goa KL,

Benfield P. ADIS Drug Information Services, Auckland, New Zealand.
Drugs 1989 Sep;38(3):389-416
http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2680435&form=6&d